- Filter by
- Categories
- Tags
- Show all
- Article
- Confusion
- Contract
- Copyright
- Corporate
- Domain Names
- Employment
- Expungement
- Expungement
- Grey Marketing
- Industrial Designs
- Licensing
- Obviousness
- Opposition
- Passing Off
- Patent
- Patent Infringement
- Patent Strategy
- PM(NOC)
- Procedure
- Prosecution
- recognition
- Services
- Summary
- Trade Secrets
- Trade-mark
- Use
- Validity
- 2019
- 3D printing
- 6.08
- abandonment
- abstract
- abstract theorems
- accounting of profits
- acquired distinctiveness
- actions
- actual notice
- agreement
- agreements
- airport security
- alice
- ambiguity
- amending
- amendment
- Amendments
- annual maintenance fee
- Anticipation
- appeal
- application
- application chain
- application fee
- arbitrary
- arbitration
- Assignment
- Australia
- bad faith
- bill
- Bill C-31
- Bill C-43
- Bill C-8
- Bill C-86
- biologics
- biosimilar
- Biotech Patents
- book launch
- border measures
- brand
- branding
- broadcasting
- budget
- burden of proof
- business
- CAFC
- calculation
- call processing
- Canada
- Canada Gazette
- canadian patent law
- causal link
- cdrp
- CEEO
- certificate of supplementary protection
- champerty
- chemical patent
- chemistry
- ciba
- CIPO
- CIPO errors
- cira
- Claim Construction
- Class Actions
- clerical error
- college of agents
- combination
- combination drugs
- commissioner
- Common General Knowledge
- complete code
- confidential
- Confidential Information
- confidentiality
- confidentiality order
- conflict of interest
- conflicts
- conflicts of interest
- confusing
- confusingly similar
- confusion
- constitution
- constitutional
- constitutionality
- contract
- contributory infringement
- Copyright
- copyright infringement
- copyright test
- corrections
- Costs
- counsel
- CSP
- cybersecurity
- damages
- Data
- Data Protection
- deadline
- deadlines
- defamation
- defences
- delay to market entry
- delayed market entry
- descriptive
- design
- design patents
- designs
- deviation
- digital infringement
- disclosure
- distinctive
- distinctive feature
- distinctiveness
- diversity
- division of powers
- divisionals
- DNA Patents
- domain
- domain names
- dominant feature
- dosage range
- Double Patenting
- doubtful cases
- due care
- e-commerce
- Early dismissal
- errors
- essentiality of elements
- Ethics
- Europe
- Evidence
- examination quality
- examination statistics
- Examiner
- expert
- expert blinding
- expert evidence
- Experts
- expiry
- Expungement
- extraterritoriality
- federal circuit
- federal court
- federal court of appeal
- fee
- fees
- file wrapper
- filing
- filing date
- filing fee
- financial services
- foreign issue estoppel
- forum selection
- fraud
- Free World Trust
- frivolous
- funding
- future infringement
- generics
- geographical indications
- global
- Good Faith
- goods
- government
- grace period
- grey marketing
- Hague
- hearsay
- hearsay evidence
- Honest Contractual Performance
- human use
- ICSID
- Illegality
- Improver
- imunity
- inclusion
- Indefiniteness
- Inducement
- industrial designs
- infringement
- inherent distinctiveness
- injunction
- Injunctions
- Innovation
- insufficiency
- insufficient disclosure
- intellectual property
- intellectual property rights
- intent
- Inter Partes Review
- interlocutory injunction
- Internet
- intra vires
- invalidated
- invalidation
- inventor removal
- inventorship
- IP
- ip lawyer
- IP management
- ip regime
- IP Strategy
- iplaw
- IPO
- ISP
- issued patents
- IT patent
- ITC
- Jurisdiction
- Late fee
- law
- law firm
- lawfirm
- lawyer
- leading lawyer
- Legal Retainer
- legal test
- legislative reform
- legitimate interest
- lexpert
- license
- licensee
- Licensing
- life science
- limitation periods
- litigation
- litigation evidence
- litigation funding agreement
- madrid
- maintenance
- material facts
- materiality
- mayo
- method
- Methods of Medical Treatment
- minister of health
- minorities
- misleading
- monopoly
- motion
- Motion to dismiss
- Motion to strike
- NAFTA
- national phase entry
- new act
- new evidence
- no chance of success
- non-infringing alternative
- non-statutory subject matter
- notice of allegation
- notice to rectify
- novelty
- obivous error
- obvious to try
- Obviousness
- Office
- official mark
- official marks
- on-sale
- on-sale bar
- Online
- ontario
- opposition
- outsourcing
- Overbreadth
- overlapping
- overpromising
- ownership
- Ownership & Inventorship
- PAB
- Passing Off
- Patent
- patent abandonment
- patent act
- patent agent
- Patent Agents
- patent appeal board
- patent application
- patent book
- patent eligibility
- patent infrigement
- patent infringement
- patent law
- patent litigation
- Patent Office
- patent office errors
- patent ownership
- patent practicioner
- patent prosecution
- patent protection
- patent requirement
- patent rules
- Patent Strategy
- patent term adjustment
- patent trolls
- patent validity
- patentability
- Patentable Subject Matter
- patented medicines
- patented medicines prices review board
- patentee
- patents
- PCT
- pharma
- pharmaceutical
- pharmaceutical patent
- pharmaceutical pricing
- plain and obvious
- PLT
- PM(NOC)
- PM(NOC) Damages
- PMNOC Regulations
- PMPRB
- posita
- price regulation
- prices
- pride
- prior art
- prior disclosure
- prior disclosure defence
- prior use
- priority
- priority claim
- priority claims
- priority date
- Privilege
- procedure
- Product Specificity
- profit
- prohibited marks
- Promise
- promise doctrine
- proprietor
- prosecution
- protective order
- prothonotaries
- provisional patent
- public sale
- Public Servant
- Punitive Damages
- quantification
- ramped-up sales
- recognition
- Records
- registration
- reinstatement
- relevant date for construction
- remedies
- representation
- request for correction
- requisition
- responding
- review
- risk
- Royalties
- s. 101
- s. 27
- s. 45
- s. 53
- sale
- Scheduling
- SCOTUS
- second person
- Secondary Infringement
- secondary meaning
- secret sale
- section 101
- section 28
- Section 45
- section 50
- Section 52
- section 56
- section 7
- security
- selection patents
- seminar
- Services
- settlement
- skilled person
- software
- Software Copyright
- Software Patent
- software patents
- Sound Prediction
- specification
- sponsorship
- springboard profits
- SRED
- Standard of Review
- standing
- standing to appeal
- Start-up
- Startups
- statute of monopolies
- statutory subject matter
- stay
- strategy
- subject matter
- Sufficiency
- Summary Judgment
- summary trial
- supreme court
- surname
- swiss
- tadalafil
- Technology
- test
- third party
- time frame
- top patent agent
- top ranked
- TPP
- trade secrets
- trade-mark
- Trade-mark Infringement
- Trade-mark Licensing
- Trade-mark Use
- trade-marks act
- trademark
- Trademark Act
- trademark agent
- trademarks
- Trademarks use
- treaty
- UK
- united kingdom
- United States
- unpatentable
- untrue material allegation
- US
- us patent law
- us supreme court
- usa
- use
- useful article
- USMCA
- USPTO
- Utility
- validity
- variant
- Varying records
- Velocity
- veterinary use
- vexatious
- wenger
- who's who legal
- women
October 5, 2016
October 5, 2016
2015 FCA 286 - An attack on the Federal Court’s slight rewording of the obvious-to-try test has proven unsuccessful. The FC referring to a 'fair expectation of success'" was not a reviewable error.
August 22, 2016
August 22, 2016
2016 FC 720 - The FC bifurcated the issues of infringement and validity from any other section 8 issue in hopes that bifurcation would likely lead to a settlement of all the issues between the parties.
May 6, 2016
May 6, 2016
2015 FC 875 - The FC noted that the law is unsettled when it comes to determining the appropriate date for assessing obvious-type double patenting.
April 11, 2016
April 11, 2016
2015 FC 570 - The FC favoured the respondent’s "blinded expert" evidence in which the experts provided their opinions before knowing what was claimed in the disputed patents.
April 5, 2016
April 5, 2016
2015 FC 125 - The existing patent was invalid on the grounds of lack of utility for having made a promise of utility that could not be demonstrated nor soundly predicted, was anticipated by a previous patent of the applicant that claimed an overlapping dosage range, and was also therefore made obvious by the same previous patent.
February 17, 2016
February 17, 2016
2015 FC 1205 - A quirk in the PM(NOC) rules was resolved that could make the entry of generics into the market even slower if the generic tries to make post-filing amendments to its application.
October 7, 2015
October 7, 2015
Gilead Sciences, Inc v Canada (Health), 2015 FC 610 - Gilead's assertion that its patent is valid would be relitigating old issues and an abuse of PM(NOC) proceedings.
May 20, 2015
May 20, 2015
The proposed amendments would dispose of the product specificity requirement that was interpreted by the Federal Court of Appeal in paragraphs 4(2)(a) and 4(2)(b) of the PM(NOC) Regulations.
February 25, 2015
February 25, 2015
Eli Lilly Canada v Canada (Attorney General), 2014 FC 152 - This decision clearly states that a higher level of specificity is required to adhere to the Regulations than is required for an element to be claimed as a matter of claim construction.